Back
Jaguar Health 10K Form
Buy
75
JAGX
Jaguar Health
Last Price:
0.31
Seasonality Move:
52.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JAGX News And Ratings
See the #1 stock for the next 7 days that we like better than JAGX
JAGX Financial Statistics
Sales & Book Value
| Annual Sales: | $9.76M |
|---|---|
| Cash Flow: | $-7.45M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.07 |
| Price / Book: | 18.41 |
Profitability
| EPS (TTM): | -3.58490 |
|---|---|
| Net Income (TTM): | $-41.3M |
| Gross Margin: | $7.72M |
| Return on Equity: | -1119.55% |
| Return on Assets: | -81.72% |
Jaguar Health Earnings Forecast
Key Jaguar Health Financial Ratios
- The Gross Profit Margin over the past 10 years for JAGX is 79.13%.
- The Selling, General & Administrative Expenses for JAGX have been equal to 236.12% of Gross Profit Margin.
- The Research & Development expenses have been 190.51% of Revenue.
- The Interest Expense is -15.45% of Operating Income.
- The Net Earning history of JAGX is -423.11% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 8 years.
Jaguar Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JAGX |
| CUSIP: | 47010C |
| Website: | jaguar.health |
Debt
| Debt-to-Equity Ratio: | 7.23 |
|---|---|
| Current Ratio: | 2 |
| Quick Ratio: | 0.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JAGX Technical Analysis vs Fundamental Analysis
Buy
75
Jaguar Health (JAGX)
is a Buy
Is Jaguar Health a Buy or a Sell?
-
Jaguar Health stock is rated a Buy
The current Jaguar Health [JAGX] share price is $0.32. The Score for JAGX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.